Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bartl

Showing results (11-20 of 123) with videos related to

Pageof 13
Sort By:
Der Unfallchirurg|September 10, 2003
[The management of manifest osteoporosis--a new responsibility for the accident specialist]R Bartl
Der Internist|March 1, 1986
[Silent onset of multiple myeloma. How to diagnosis and when to treat?]R Bartl
Deutsche Medizinische Wochenschrift (1946)|December 11, 2008
[A query from medical practice: the biological half-life of biphosphonates]R Bartl
Der Internist|August 16, 2008
[Treatment of osteoporosis according to the "European Guidance 2008". Fracture-oriented--economical--cost-effective]R Bartl
Deutsche Medizinische Wochenschrift (1946)|April 26, 2007
[Practical guidelines for the management of osteoporosis--evidence-based and cost-effective]R Bartl
Deutsche Medizinische Wochenschrift (1946)|March 19, 2009
[Biologic half-life of bisphosphonates]R Bartl
Leukemia Research|January 1, 1992
Minimal diagnostic criteria for the myelodysplastic syndrome (MDS) in clinical practiceB Frisch, R Bartl
Der Internist|October 11, 2015
[Current prevention and treatment strategies for osteoporosis. Fracture-oriented, effective, low side effects and inexpensive]R Bartl, C Bartl
Der Radiologe|April 2, 2011
[Secondary osteoporosis: pathogenesis, types, diagnostics and therapy]C Bartl, R Bartl
Scandinavian Journal of Haematology. Supplementum|January 1, 1986
Bone marrow histology in myelodysplastic syndromesB Frisch, R Bartl
Pageof 13

Showing results (11-20 of 123) with videos related to

Sort By:
Pageof 13
Der Unfallchirurg|September 10, 2003
[The management of manifest osteoporosis--a new responsibility for the accident specialist]R Bartl
Der Internist|March 1, 1986
[Silent onset of multiple myeloma. How to diagnosis and when to treat?]R Bartl
Deutsche Medizinische Wochenschrift (1946)|December 11, 2008
[A query from medical practice: the biological half-life of biphosphonates]R Bartl
Der Internist|August 16, 2008
[Treatment of osteoporosis according to the "European Guidance 2008". Fracture-oriented--economical--cost-effective]R Bartl
Deutsche Medizinische Wochenschrift (1946)|April 26, 2007
[Practical guidelines for the management of osteoporosis--evidence-based and cost-effective]R Bartl
Deutsche Medizinische Wochenschrift (1946)|March 19, 2009
[Biologic half-life of bisphosphonates]R Bartl
Leukemia Research|January 1, 1992
Minimal diagnostic criteria for the myelodysplastic syndrome (MDS) in clinical practiceB Frisch, R Bartl
Der Internist|October 11, 2015
[Current prevention and treatment strategies for osteoporosis. Fracture-oriented, effective, low side effects and inexpensive]R Bartl, C Bartl
Der Radiologe|April 2, 2011
[Secondary osteoporosis: pathogenesis, types, diagnostics and therapy]C Bartl, R Bartl
Scandinavian Journal of Haematology. Supplementum|January 1, 1986
Bone marrow histology in myelodysplastic syndromesB Frisch, R Bartl
Pageof 13